Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.Jump to contentThank you for registeringPlease refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged inAllNewsSportCultureLifestyleThe UK’s first GLP-1 pill for weight loss has been approved by the medicines regulator (Alamy/PA) (Alamy/PA)The medicines regulator has approved Wegovy, the UK’s first GLP-1 pill for weight loss, a daily semaglutide tablet. It is prescribed for obese adults with a BMI of 30 or above, or those who are overweight with a related condition such as high blood pressure.The dosage starts at 1.5mg and gradually increases to 25mg, with patients needing to be on each dose level for at least a month before moving up to the next.The Medicines and Healthcare products Regulatory Agency (MHRA) approved the drug based on data from a trial that demonstrated an average body weight loss of 17 per cent after 64 weeks for adults taking the 25mg daily pill alongside diet and exercise. The drug will be available privately within weeks, though it has not yet been assessed for use on the NHS.In fullFirst daily pill for weight loss approved by medicines regulatorThank you for registeringPlease refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in

Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.Jump to contentThank you for registeringPlease refresh the page or…

As exclusively revealed by the Daily Mail last week, the Wegovy Pill - the tablet form of the once-weekly Wegovy injection - has been greenlit by health officials.

A new prescription-only weight loss tablet has been approved for use in the UK for people who are overweight and have a related condition like high blood pressure

Regulator approval means patients who meet criteria such as having obesity will be able to purchase pills with private prescription

Novo Nordisk wins U.K. approval for Wegovy pill, offering adults a daily oral weight-loss option backed by Phase 3 trial data.

Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.Jump to contentThank you for registeringPlease refresh the page or…

Britain's regulator has approved Novo Nordisk's weight-loss pill, marking the UK's entry as the first European market for this oral obesity treatment.

Health chiefs have given the go-ahead for a tablet form of the weight loss drug to be used in the UK - full details of who can get it, how and when it will be available

Private waiting lists have already soared as Britons scramble to secure the game-changing treatment, which can help people with obesity lose up to 17 per cent of their body weight…